Skip to main content

Biopharma Startups

Updated October 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 906 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
906
Total Funding
$630.2M
Avg Funding
$25.2M
Global Reach
6
countries

Top Cities for Biopharma

Ann Arbor
Marseille
Bristol
San Mateo
Andover
San Francisco

Recently Funded Companies

Export
Ann Arbor, United States

Evoq Therapeutics is a cancer immunotherapy company that provides disease-specific immune modulators.

$2.0M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Marseille, France

ImCheck Therapeutics designs and develops immunotherapeutic antibodies for the treatment of cancer and autoimmune disease.

$22.4M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Bristol, United Kingdom

EnsiliTech is a biopharmaceuticals company that preserves the integrity of vaccines and other biological materials.

$6.1M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

San Mateo, United States

AusperBio is a biotechnology company focused on developing oligonucleotide therapeutics and targeted delivery technologies.

$120.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Andover, United States

Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.

$1.8M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Terraton is a biochar platform that provides equipment, design, and financing to agribusiness operators.

$11.5M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Cincinnati, United States

Optimvia is a biopharmaceutical company that specializes in engineering proteins with tailored functions to combat disease.

$523K raised
Aug 2024

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Axiom Therapeutics is a health tech company that provides computational drug discovery solutions for untreatable cancers.

$12.3M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

3T Biosciences is an immunotherapy company that develops next-generation therapies for cancer and immune-mediated diseases.

$40.0M raised
Aug 2022

Founder Contacts

41,000+ verified contacts

Hanover, Germany

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

$75.3M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

New York, United States

Ceramedix Holding is a biotherapeutics company that develops antibody-based drugs with the aim of addressing novel diseases.

$3.0M raised
Aug 2023

Founder Contacts

41,000+ verified contacts

Macclesfield, United Kingdom

The SkinBioTherapeutics platform applies research discoveries made on the activities of lysates derived from probiotic bacteria.

$2.0M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Princeton, United States

4M Therapeutics Inc. (4MTx) develops therapies for central nervous system (CNS) disorders with blockbuster potential.

Aug 2025

Founder Contacts

41,000+ verified contacts

Burlingame, United States

Inversion Therapeutics is a biotechnology company that offers healthcare related services.

$6.9M raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Carlsbad, United States

Cisterna Biologics is a technology company that aims to solve the biotech industry's main challenges in developing mRNA-based therapeutics

$500K raised
Aug 2022

Founder Contacts

41,000+ verified contacts

Baltimore, United States

Cerecor discovers, develops and commercializes neuroscience drugs.

$10.0M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

Radnor, United States

Mitochon Pharmaceuticals is a start-up biotech company.

$1.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Raleigh, United States

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

$105.0M raised
Aug 2024

Founder Contacts

41,000+ verified contacts

Greensboro, United States

LifeCyte Innovations develops therapies targeting chronic inflammation to slow age-related diseases, including AMD and cognitive decline.

$1.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Little Rock, United States

Captura Biopharma is an emerging biotechnology company engaged in the development and commercialization of heavy metal chelators.

$50.0M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

Molcure is a high-speed, high-quality, high-variation antibody screening & design system combining biology, automation and bioinformatics

$7.3M raised
Aug 2021

Founder Contacts

41,000+ verified contacts

San Juan, Puerto Rico

MBQ Pharma is a pharmaceutical company that develops a solution for preventing the spread of cancer cells in the body.

$991K raised
Aug 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

CellChorus applies visual AI to evaluate how individual cells move, behave, and interact.

$200K raised
Aug 2025

Founder Contacts

41,000+ verified contacts

Mountain View, United States

NeuCyte is an early-stage biotech focused on advancing the early phases of CNS drug discovery programs for Lead Compound Optimization.

$500K raised
Aug 2023

Founder Contacts

41,000+ verified contacts

Palo Alto, United States

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

$150.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Showing 101 to 125 of 906 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 906 biopharma companies tracked in the VCBacked database.

Average Funding
$25.2M
Total Funding Tracked
$630.2M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Ann Arbor
1 companies$2.0M
2.Marseille
1 companies$22.4M
3.Bristol
1 companies$6.1M
4.San Mateo
1 companies$120.0M
5.Andover
1 companies$1.8M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

906 Biopharma Startups (2026) — Recently Funded — Page 5 | VCBacked